DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Temocapril
Temocapril
Effects of Monotherapy of Temocapril Or Candesartan with Dose Increments Or Combination Therapy with Both Drugs on the Suppression of Diabetic Nephropathy
Supplementary Appendix 1. Search Strategy for the Systematic Review and Meta-Analysis
Renoprotective Effect of the Addition of Losartan to Ongoing Treatment with an Angiotensin Converting Enzyme Inhibitor in Type-2 Diabetic Patients with Nephropathy
Combination Therapy with Olmesartan and Temocapril Ameliorates Renal Damage and Upregulates the Klotho Gene in 5/6 Nephrectomized Spontaneously Hypertensive Rats
“Captopril” [Mesh
Quantify Chronic Kidney Disease Clinical Outcomes Database
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Use of Antitussives After the Initiation of Angiotensin-Converting Enzyme Inhibitors
Effects of Long-Acting ACE Inhibitor (Temocapril) and Long-Acting Ca Channel Blocker (Amlodipine) on 24-H Ambulatory BP in Elderly Hypertensive Patients
Comparative Proteinuria Management of Different Angiotensin-Converting Enzyme Inhibitors Or Angiotensin Receptor Blockers for No
Telmisartan Versus Angiotension-Converting
Effect of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker on the Patients with Sepsis
Supplementary Information
Pharmacokinetics of Temocapril and Temocaprilat After 14 Once Daily Oral Doses of Temocapril in Hypertensive Patients with Varying Degrees of Renal Impairment
Selective AT2 Receptor Agonists for Use in Treatment of Cachexia
(CGRP)-Containing Nerves in Spontaneously Hypertensive Rats
Angiotensin-Converting Enzyme Inhibitor Induced Cough in Chinese Patients: a Systematic Review and Meta-Analysis
Evaluation of Symptomatic Improvements Observed By
Top View
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Angiotensin-Converting Enzyme Inhibitor Does Not Suppress Renal Angiotensin II Levels in Angiotensin I–Infused Rats
Combination Therapy Based on the Angiotensin Receptor Blocker Olmesartan for Vascular Protection in Spontaneously Hypertensive Rats
Long-Term Renoprotective Effect of Combination Therapy with Prostaglandin E1 and Angiotensin- Converting Enzyme Inhibitor in Patients with Chronic Renal Failure
Modern Development in ACE Inhibitors
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Microalbuminuria Reduction with Telmisartan in Normotensive And
Angiotensin-Converting Enzyme Inhibitors
Psoriasis Associated with ACE Inhibitors: an Analysis of the FAERS Database
Appendix A: Search Strategies Number of Citations in () / After an Index Term Indicates That All Subheadings Were Selected
Effects of the Angiotensin-Converting Enzyme Inhibitor Alacepril in Dogs with Mitral Valve Disease
Supplemental Data
Beneficial Effects of Combination Therapy with Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor on Va
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
An Application to Include Blood Pressure Lowering Drug Fixed Dose
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Download Main Document
Supplementary Appendix